# Mesoblast (MESO) — Overview

MESO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/meso

## Price

Last close $13.95 on Oct 15, 2026. 52-week range $13.19 – $20.96.

## Company profile

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $120.3M |
| Revenue (quarter) | $120.3M |
| Revenue growth (year over year) | 599.21% |
| Gross profit (trailing twelve months) | $103.6M |
| Gross margin | 86.14% |
| Net income (trailing twelve months) | −$57.5M |
| Net income (quarter) | −$57.5M |
| Net income growth (year over year) | 43.71% |
| Net margin | -47.82% |
| Return on equity | -9.86% |
| EPS (trailing twelve months) | −$0.44 |
| Book value per share | $4.38 |
| P/E (trailing twelve months) | — |
| Price to book | 3.2 |
| Debt to assets | 26.48% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Mesoblast (MESO) profitable?

No. Mesoblast reported a net loss of $57.5M over the trailing twelve months.

### How much revenue does Mesoblast (MESO) make?

Mesoblast generated $120.3M in revenue over the trailing twelve months, up 599.21% year over year.

### How do I buy stock in Mesoblast (MESO)?

MESO trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).